Related Experiment Videos
Heart and heart-lung transplantation, Papworth Hospital, 1979-1989
S R Large1, T A English, J Wallwork
1Papworth Hospital, Cambridge, England.
Insights
Heart transplantation offers a good quality of life for survivors and is an established therapy for heart disease. Heart-lung transplantation is developing, with ongoing research into long-term outcomes.
Area of Science:
- Cardiology
- Transplantation Medicine
Background:
- Heart transplantation is an established therapy for end-stage heart disease.
- Heart-lung transplantation is in its developmental phase with acceptable short-term results.
- Quality of life for transplant survivors is generally good, with reduced hospital stays and costs.
Purpose of the Study:
- To review the current status and future directions of heart and heart-lung transplantation.
- To identify challenges and areas for improvement in transplant services.
Main Methods:
- Review of established principles in heart and heart-lung transplant management.
- Analysis of trends in hospital stay duration and cost.
- Discussion of factors influencing medium and long-term outcomes.
Main Results:
- Heart transplantation is a proven therapeutic option for life-threatening heart conditions.
- Improvements in transplant services are needed to meet increasing demand.
- Donor organ limitation is a significant logistical challenge.
Conclusions:
- Further improvements in immunosuppression and understanding of chronic organ damage are anticipated.
- Addressing chronic damage in heart and heart-lung transplants is crucial for long-term survival.
- Heart transplantation is a well-established option, while heart-lung transplantation continues to evolve.
Abstract:
The quality of life for those who survive the first 3 months after transplantation is generally good (10). The duration of hospital stay and the cost of transplantation per patient has been reduced during the last 3 years. Cardiologists are coming to appreciate the therapeutic potential of both heart and heart-lung transplantation. One of the chief logistical problems now being faced is that of increasing the provision of transplant services to match the increasing demand. It was said in an earlier edition of this book that this would be donor organ limited and that pattern already seen in the United States is becoming apparent in the United Kingdom. The broad principles of management of heart and heart-lung recipients have been established. Further improvements in medium and long-term results can be anticipated as a result of refining immunosuppression and defining the cause of chronic donor organ related damage (small vessel coronary occlusive disease in heart transplants and chronic obliterative bronchiolitis in heart-lung transplants). Heart transplantation has become firmly established as a therapeutic option for life threatening heart disease. It is probably too early to attribute this label to heart-lung transplantation which continues through its developmental phase with acceptable short-term results. Improvements in chronic damage characteristic of long-term survival in both heart and heart-lung transplant recipients will be a significant clinical step forward in this field.